Table-3.
The prevalence of anti-C. burnetii antibodies by IFA for the detection of IgM and IgG antibodies in patients in hospitals in the Assiut district.
| Case report | No. of samples | No. of positive IFAT % | H1 | H2 | H3 | |||
|---|---|---|---|---|---|---|---|---|
| IgM | IgG | IgM | IgG | IgM | IgG | |||
| Fever | 46 | 24 52.1% | 3/16 18.75% | 5/16 31.3% | 2/20 10% | 8/20 40% | 2/10 20% | 4/10 40% |
| Flu | 23 | 7 30.4% | 1/5 20% | 1/5 20% | 2/14 14.3% | 2/14 14.3% | 1/4 25% | 0/4 0% |
| Kidney dialysis | 8 | 3 37.5% | 0/3 0% | 1/3 33.3% | 1/3 33.3% | 1/3 33.3% | 0/2 0% | 0/2 0% |
| IHCV | 27 | 20 74.1% | 2/8 25% | 4/8 50% | 3/12 25% | 7/12 58.3% | 1/7 14.3% | 3/7 42.9% |
| IHBV | 16 | 10 62.5% | 1/6 16.7% | 2/6 33.3% | 2/7 28.6% | 3/7 42.9% | 1/3 33.3% | 1/3 33.3% |
| Total | 120 | 64 53.3% | 7/38 18.4% | 13/38 34.2% | 10/56 17.9% | 21/56 37.5% | 5/26 19.2% | 8/26 30.8% |
IHCV =Infectious hepatitis C virus, IHBV=Infectious hepatitis B virus, H1= Hospital 1, H2= Hospital 2, H3=hospital 3. IFA=Immunofluorescence assay, C. burnetii=Coxiella burnetii